Skip to main content
. 2021 Sep 20;14(9):941. doi: 10.3390/ph14090941

Figure 4.

Figure 4

Modes of antibiofilm activity against P. aeruginosa IBRS P001 expressed as percentage inhibition compared to the untreated control. (A) Inhibition of biofilm cell viability determined by MTT assay. (B) Inhibition of biofilm exopolysaccharide content. (C) Inhibition of biofilm eDNA. (D) Inhibition of biofilm CFU formed on urinary catheters. Results are expressed as mean (±stdev) of triplicates.